Form 4 for ABT Abbott Laboratories
Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0001415889-24-006417 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-04 | 2024-03-01 | ABT | Salvadori Daniel Gesua Sive | EVP | S - Sale | $118.50 | -963 | 125.7K | -0.8% | -$114.1K | |
| 2024-03-04 | 2024-02-29 | ABT | Salvadori Daniel Gesua Sive | EVP | F - Tax | $120.05 | -8,874 | 126.7K | -7% | -$1.07M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2024-03-01 | S | D | 963 | $118.50 | 125,697 | D | — | — | |
| 2 | Common | Common shares without par value | 2024-02-29 | F | D | 8,874 | $120.05 | 126,660 | D | — | — |